Glioblastoma: background, standard treatment paradigms, and supportive care considerations. J Law Med Ethics 2014;42:171-82.Ellor, S. V., Pagano-Young, T. A. & Avgeropoulos, N. G. Glioblastoma: background, standard treatment paradigms, and supportive care considerations. J. Law Med. Ethics...
With the recent approval by the FDA of an immunotherapy for prostate cancer and another positive immunotherapy trial in melanoma, immunotherapy may finally be coming of age. So what will it take for it to become part of the standard treatment for glioblastoma? To put this question into perspecti...
This review will focus on the development of temozolomide and its use along with radiation therapy as the current standard treatment for glioblastoma. 展开 关键词: Glioblastoma temozolomide radiation DOI: 10.1097/PPO.0b013e318244d7eb 被引量: 87 ...
Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma. Journal of Clinical Medicine. 2019; 8(11):2007. https://doi.org/10.3390/jcm8112007 Chicago/Turabian Style Cuccarini, Valeria, Domenico Aquino, Andrea Gioppo, Elena Anghileri, Serena Pelle...
Now for the "dismal" part. The Stupp protocol, despite its position as a cornerstone of modern glioblastoma treatment, is not very effective. It does appear to be better than nothing and alternatives that are no longer used, but that's a very low bar....
Lomustine probably remains the most widely used drug second only to temozolomide in the treatment of gliomas. Despite all limitations summarized above, it is defined as the main standard of care for recurrent glioblastoma in Europe, where bevacizumab is not approved, in the EANO guideline [30]...
THIO has also shown promise in preclinical studies as a treatment for glioblastoma. In November 2023, the FDA granted orphan drug designation to the agent in this disease state.5 In 2022, THIO was also granted orphan drug designations from the FDA in hepatocellular carcinoma and small cell lung...
Although glioblastoma... D Harwood,S Michaelsen,B Kristensen - 《Cancer Research》 被引量: 0发表: 2022年 Formulation and Evaluation of Fluvastatin Loaded Solid Lipid Nanoparticles In the present work Fluvastatin was taken which is anti-hyper lipidemic drug used for chronic treatment. It bel...
Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigensantiangiogenic agentsEGFR variant IIIglioblastomaisocitrate dehydrogenasemalignant glioma
"In the past 20 years, RUBY is the only phase 3 clinical study to demonstrate a statistically significant improvement in overall survival compared to platinum-based monotherapy, the standard of care for first-line treatment in patients with advanced or recurrent endometrial cancer," said Yang Yoo-...